Omega-3 reduces side effects of Cancer treatments

Created April 2019

Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications

Nutrients 2019, 11(5), 945; https://doi.org/10.3390/nu11050945

Raquel D. S. Freitas 1,2 and Maria M. Campos 1,2,3,*

Items in both categories Cancer – after diagnosis and Omega-3 are listed here: {category} Items in both categories Cancer – Breast and Omega-3 are listed here: {category} Omega-3 also PREVENTS some Cancers, thus eliminating the need for treatment * Low-Grade Prostate Cancer 70 percent less likely to progress if good level of Omega-3 – June 2018 * Omega-3 prevents and treats several cancers – Sept 2017 * Severe acute pancreatitis treated in 11 ways by Omega-3 in just 7 days – RCT April 2018 * Omega-3 should help Pancreatic Cancer in 5 ways – June 2017

📄 Download the PDF from VitaminDWiki ]

image

image

Cachexia (Weakness or wasting of the body)

image

image

Omega-3 polyunsaturated fatty acids (PUFAs) are considered immunonutrients and are commonly used in the nutritional therapy of cancer patients due to their ample biological effects. Omega-3 PUFAs play essential roles in cell signaling and in the cell structure and fluidity of membranes. They participate in the resolution of inflammation and have anti-inflammatory and antinociceptive effects. Additionally, they can act as agonists of G protein-coupled receptors, namely, GPR40/FFA1 and GPR120/FFA4.

Cancer patients undergo complications, such as

  • anorexia-cachexia syndrome,

  • pain,

  • depression, and

  • paraneoplastic syndromes.

Interestingly, the 2017 European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines for cancer patients only discuss the use of omega-3 PUFAs for cancer-cachexia treatment, leaving aside other cancer-related complications that could potentially be managed by omega-3 PUFA supplementation. This critical review aimed to discuss the effects and the possible underlying mechanisms of omega-3 PUFA supplementation in cancer-related complications. Data compilation in this critical review indicates that further investigation is still required to assess the factual benefits of omega-3 PUFA supplementation in cancer-associated illnesses. Nevertheless, preclinical evidence reveals that omega-3 PUFAs and their metabolites might modulate pivotal pathways underlying complications secondary to cancer, indicating that this is a promising field of knowledge to be explored.

Tags: Cancer Cancer - after diagnosis Omega-3